Suleman Idris Hadejia

Prof. Dr. Suleman Idris Hadejia

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in Nigerian Medical Journal
Verified
Journal Article
Open access
PDF file
SHSuleman Idris Hadejia
Suleman Idris Hadejia
MSMohammed Nasir Sambo
Mohammed Nasir Sambo
MIMuhammed Sani Ibrahim
Muhammed Sani Ibrahim
Background: Low level of utilisation of maternal health services is a major factor responsible for high maternal mortality in northwestern region of Nigeria. This study was aimed at determining the barriers to utilisation of maternal health services from the perspective of mothers in northwestern Nigeria. Materials and Methods: A cross-sectional study of 150 mothers, selected through multistage technique, was conducted. Data were collected using a structured interviewer-administered questionnaire, and analysed using SPSS statistics 17.0. Results: Only 2.7% utilised preconception service, 98.7% antenatal care service (ANC), 24.0% delivery, 35.3% postnatal care and 14.0% utilised family planning service. Major reasons for non-utilisation of delivery service were not having a delivery complication in the past (57% (CI = 47.4-66.1)) and negative provider attitude (23.7% (CI = 16.4-32.7)). For non-utilisation of postnatal care, the major reasons were also not having a postnatal complication in the past (60.8% (CI = 50.4-70.4)) and negative provider attitude (27.8% (CI = 19.4-38.0)). As for non-utilisation of family planning service, the major reason was desire to have more children (32.6% (CI = 24.7-41.4)). Reasons for non-use of preconception care and ANC were not computed because respondents to these questions were not enough; only 6 (4.0%) were aware of preconception care in the first place and only 2 (1.3%) were not using ANC. Conclusion: Despite living near a health facility, most of the mothers were not using maternal health services. It is recommended that while there is the need to raise awareness on the utilisation of maternal health services, bring it closer to the mothers and make it more affordable, there is a more pressing need to improve its quality, especially through the alleviation of negative attitude of health care providers.

17 March 2023 in Vaccines
Verified
Journal Article
Open access
PDF file
JSJessica Catherine Shearer
Jessica Catherine Shearer
ONOlivia Nava
Olivia Nava
WPWendy Prosser
Wendy Prosser
SNSaira Nawaz
Saira Nawaz
SMSalva Mulongo
Salva Mulongo
GCGrace Chee
Grace Chee
Background: The importance of immunization for child survival underscores the need to eliminate immunization inequalities. Few existing studies of inequalities use approaches that view the challenges and potential solutions from the perspective of caregivers. This study aimed to identify barriers and context-appropriate solutions by engaging deeply with caregivers, community members, health workers, and other health system actors through participatory action research, intersectionality, and human-centered design lenses. Methods: This study was conducted in the Demographic Republic of Congo, Mozambique and Nigeria. Rapid qualitative research was followed by co-creation workshops with study participants to identify solutions. We analyzed the data using the UNICEF Journey to Health and Immunization Framework. Results: Caregivers of zero-dose and under-immunized children faced multiple intersecting and interacting barriers related to gender, poverty, geographic access, and service experience. Immunization programs were not aligned with needs of the most vulnerable due to the sub-optimal implementation of pro-equity strategies, such as outreach vaccination. Caregivers and communities identified feasible solutions through co-creation workshops and this approach should be used whenever possible to inform local planning. Conclusions: Policymakers and managers can integrate HCD and intersectionality mindsets into existing planning and assessment processes, and focus on overcoming root causes of sub-optimal implementation.

14 August 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
DADamilare Michael Akintunde
Damilare Michael Akintunde
RBRosie Burton
Rosie Burton
MOMichael Olaleye
Michael Olaleye
OAOmotolani O. Akintunde
Omotolani O. Akintunde
SHSuleman Idris Hadejia
Suleman Idris Hadejia
Introduction: Noma is a severe gangrenous orofacial disease affecting malnourished children aged 2–6 years in extreme poverty, with 85–90% mortality if untreated. Recently classified as a Neglected Tropical Disease, it is managed mainly with empirical broad-spectrum antibiotics. Antimicrobial resistance (AMR) threatens to undermine treatment, yet AMR remains largely absent from Noma research and policy. This review examines AMR prevalence and drivers in Noma, identifies knowledge and policy gaps, and proposes recommendations.Methods: We reviewed literature on Noma microbiology and documented AMR, plus WHO NTD and AMR policy documents. Community and health system factors and surveillance capacity in Noma-endemic regions, primarily Sub-Saharan Africa, were synthesized.Results: Noma lesions show marked dysbiosis with frequent detection of Fusobacterium necrophorum, Prevotella spp., Staphylococcus aureus, Pseudomonas aeruginosa, and a novel “Treponema sp. A”. A 25-year retrospective analysis found that >92% of patients presented late, requiring prolonged antibiotics. Direct AMR data are scarce. Case reports documented MDR-Escherichia coli in Afghanistan(2012), Vancomycin-resistant Enterococci in South Korea(2022), ESBL E. coli in Mali(2021), Serratia marcescens (Ticarcilline, amoxicillin, and sulfamethoxazole-trimethoprim) and Pseudomonas aeruginosa (Rifampicin) in Chad (2014); and Pseudomonas aeruginosa (penicillins, carbapenems, aminoglycosides, sulfamethoxazole-trimethoprim, and nitrofurantoin) in Italy (2015). A recent metagenomic study reported high β-lactam and metronidazole resistance determinants, especially in Prevotella spp. Drivers include empirical broad-spectrum antibiotic use, self-medication, irrational prescribing, and weak diagnostics, with only a small share of laboratories across 14 SSA countries performing routine bacteriology and susceptibility testing. Policy gaps persist: WHO NTD and AMR strategies are siloed, anaerobes are excluded from GLASS surveillance, and Noma guidelines lack AMR triggers. Conclusion: AMR risks reversing gains in Noma control, and treatment centers may become AMR amplification sites without stewardship. Given limited microbiology data, we recommend adding AMR indicators to WHO and national Noma strategies, integrating anaerobic AMR surveillance at sentinel sites, generating Noma-specific antibiograms, and mandating antimicrobial stewardship in Noma programs. Mainstreaming AMR in Noma research and policy is essential to preserve therapeutic options.

18 August 2026 in Journal of Applied Health Sciences and Medicine
Verified
Journal Article
Open access
AAAminu Aliyu
Aminu Aliyu
SHSuleman Idris Hadejia
Suleman Idris Hadejia
IMIbrahim Musa Moi
Ibrahim Musa Moi
YKYahaya Mohammed Ktagum
Yahaya Mohammed Ktagum
AMAbuhuraira Ado Musa
Abuhuraira Ado Musa
Malarial disease remains a cornerstone in public health causing greater challenge in lowand middle-income countries (LMICs), in sub Saharan Africa where healthcare cost and financing is predominantly dependent on out-of-pocket (OOP) expenditure. This current systematic review examines the effect of healthcare costs on malarial disease treatment choices in LMICs, with emphasis on self medication, direct and indirect costs, over-thecounter treatment, herbal medicine treatment, and selection of antimalarial drug. This review assessed and utilized evidence from previous pure and empirical studies and the recent peer-reviewed literature published from 2020 to 2026. Online electronic databases including PubMed, Scopus, Web of Science, ScienceDirect, MEDLINE, and Google Scholar were accessed and searched using predefined keywords and Boolean operators. Many studies total to 63 were analyzed where 51 were found eligible and included in the study which included observational, qualitative, and mixed-methods studies conducted in LMICs related to malaria that explored healthcare costs and malaria treatment-seeking behavior. Findings indicated that direct medical costs such as consultation fees, laboratory investigations fees, cost of medications, and hospitalization expenses significantly influenced treatment decisions and options. While indirect costs including transportation, productivity losses, caregiver burden, and time away from work also affected healthcare utilization and influenced treatment choice and recovery outcomes. It is also found that rising healthcare costs contributed to delayed treatment-seeking behavior, increased self-medication, overthe-counter drug purchases, herbal remedy utilization, and preference for cheaper but less effective antimalarial drugs among the vulnerable population. This review concludes that healthcare costs remain the major determinant of malaria treatment choice in LMICs and recommends evaluation and expansion of subsidized malaria treatment programs, improved health insurance coverage across the region, and strengthened primary healthcare services to reduce financial barriers and improve malaria treatment outcomes.